• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Genentech

Related Topics

  1. Rogers Corporation
  2. Roche Holding AG ADR
  3. Roche Holding AG
  4. USAA Large Growth
  5. USAA Large Value
  6. USAA Large Blend

Popular Topics

  1. Sears Holdings
  2. MarkWest Energy Partners
  3. Emerging Markets
  4. Stock Market
  5. European Union

Genentech

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

    Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

  2. Genentech ’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer

    Genentech ’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer

  3. Research and Markets: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

    Research and Markets: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

  4. FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer

    FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer

  5. BioTime Appoints Franklin Berger to Board of Directors

    BioTime Appoints Franklin Berger to Board of Directors

  6. Correction to FDA Medication Errors Warning Story

    Correction to FDA Medication Errors Warning Story

  7. ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results and Provides Quarterly Update

    ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results and Provides Quarterly Update

  8. Research and Markets: Systemic Lupus Erythematosus - Pipeline Review, H1 2013

    Research and Markets: Systemic Lupus Erythematosus - Pipeline Review, H1 2013

  9. Freeman: The Next Growth Opportunities

    Veteran growth manager Richie Freeman on the bright prospects for biotechnology, LED lighting, flash memory, and the outlook for energy in light of the Gulf oil spill.

  10. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

123
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.